Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sonnerie VC is a pre-seed venture capital fund founded by Columbia alumni in New York. Established to support early-stage startups, the firm focuses on U.S. healthcare and technology companies operating in regulated markets. The fund has a reported size of $1 million, positioning it as an emerging manager in the venture capital landscape.
The firm aims to back visionary founders by providing not only capital but also operational insights and access to a global network. This approach is designed to help startups navigate the complexities of commercialization and compliance, which are critical in the healthcare and technology sectors.
Sonnerie VC has made a notable impact by emphasizing its commitment to supporting founders facing unique challenges. The general partners bring significant experience, including a strategic exit of $1.3 billion in the healthcare and technology space, which informs their investment strategy and operational support.
Sonnerie VC invests primarily in early-stage startups within the healthcare and technology sectors. The fund specifically targets companies that encounter commercialization and compliance barriers, which are common in regulated markets. This focus allows Sonnerie VC to identify and support startups that have the potential to make significant impacts in their respective fields.
The investment strategy is heavily influenced by the general partners' previous experiences, particularly their strategic exit of $1.3 billion. This background provides a strong foundation for understanding the challenges and opportunities within the healthcare and technology sectors. The firm seeks to partner with founders who demonstrate vision and resilience, essential traits for navigating the complexities of these industries.
Investment checks typically occur at the pre-seed and seed stages, aligning with the firm's mission to support early-stage companies. Sonnerie VC's geographic focus is on the United States, ensuring that they can provide localized support and insights to their portfolio companies.
Sonnerie VC's portfolio includes notable companies such as:
Sonnerie VC's focus on healthcare startups is evident in its investment in BMI OrganBank, which addresses critical challenges in organ transplantation. The firm's commitment to supporting companies that face commercialization and compliance barriers is reflected in its selection of portfolio companies.
Tomasz Felpel: Managing Partner. Tomasz has a background in venture capital and has been instrumental in guiding startups through the early stages of growth. His expertise lies in operational strategy and market entry.
Joe Park: Managing Partner. Joe brings extensive experience in the healthcare sector, having worked with various startups to navigate regulatory challenges and achieve successful exits.
Brad Kligman: Venture Partner. Brad has a strong background in technology investments and has been involved in several successful funding rounds for early-stage companies.
Paul Kwak: Venture Partner. Paul specializes in compliance and regulatory issues, providing valuable insights to portfolio companies in the healthcare sector.
Natalia Felpel: Associate. Natalia supports the investment team with research and analysis, focusing on identifying promising startups in the healthcare and technology sectors.
To pitch Sonnerie VC, founders should use the contact information provided on their website. It is recommended to include a detailed business plan, market analysis, and specific information on how the startup addresses compliance challenges in the healthcare or technology sectors. Founders should expect a response time of approximately two to four weeks after submission.
Warm introductions are preferred, as they can enhance the likelihood of a favorable review. However, cold pitches are also accepted through the website.
As of April 2026, Sonnerie VC has been actively promoting its mission and portfolio through its website. The firm highlights its focus on healthcare and technology startups, particularly those facing commercialization and compliance barriers. However, no recent blog posts or additional public activity have been detected.
Sonnerie VC continues to position itself as a key player in the pre-seed investment space, particularly in New York, where it has been recognized as one of the best active pre-seed investors.
What are Sonnerie VC's investment criteria?
Sonnerie VC focuses on early-stage startups in the healthcare and technology sectors, particularly those facing commercialization and compliance barriers. The firm seeks visionary founders who demonstrate resilience and a strong understanding of their market.
How can I apply or pitch to Sonnerie VC?
Founders can pitch to Sonnerie VC through their website at sonnerievc.com. It is advisable to include a clear business plan, market analysis, and details on how the startup addresses compliance challenges in the healthcare or technology sectors.
What makes Sonnerie VC different from other investors?
Sonnerie VC differentiates itself by focusing specifically on healthcare and technology startups in regulated markets. The general partners bring a wealth of experience, including a strategic exit of $1.3 billion, which informs their investment approach and operational support.
What is the geographic scope of Sonnerie VC's investments?
The firm primarily invests in startups located in the United States, allowing them to provide localized support and insights to their portfolio companies.
What is the typical fund size and check size for Sonnerie VC?
Sonnerie VC has a fund size of $1 million, which is considered small for the venture capital industry. The firm typically invests at the pre-seed and seed stages, aligning with its focus on early-stage companies.
What kind of post-investment involvement does Sonnerie VC have?
Sonnerie VC provides operational insights and access to a global network to help portfolio companies scale effectively. The firm is committed to supporting founders throughout their journey, particularly in navigating the complexities of commercialization and compliance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.